CN106039074A - Tablets for treating canine parvovirus - Google Patents
Tablets for treating canine parvovirus Download PDFInfo
- Publication number
- CN106039074A CN106039074A CN201610548199.0A CN201610548199A CN106039074A CN 106039074 A CN106039074 A CN 106039074A CN 201610548199 A CN201610548199 A CN 201610548199A CN 106039074 A CN106039074 A CN 106039074A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- dog
- medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000701931 Canine parvovirus Species 0.000 title claims abstract description 37
- 241000756943 Codonopsis Species 0.000 claims abstract description 17
- 241000218176 Corydalis Species 0.000 claims abstract description 16
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims description 114
- 229940079593 drug Drugs 0.000 claims description 48
- 241000628997 Flos Species 0.000 claims description 29
- 241001199012 Usta Species 0.000 claims description 21
- 239000003864 humus Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 19
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 18
- 244000113306 Monascus purpureus Species 0.000 claims description 16
- 235000002322 Monascus purpureus Nutrition 0.000 claims description 16
- 229940057059 monascus purpureus Drugs 0.000 claims description 16
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 15
- 239000009806 pulsatillae Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 239000012141 concentrate Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 235000019359 magnesium stearate Nutrition 0.000 claims description 9
- 239000013521 mastic Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 6
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 abstract description 152
- 230000000694 effects Effects 0.000 abstract description 49
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000206469 Pulsatilla Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 229940026314 red yeast rice Drugs 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 55
- 201000010099 disease Diseases 0.000 description 50
- 210000004369 blood Anatomy 0.000 description 40
- 239000008280 blood Substances 0.000 description 40
- 210000002784 stomach Anatomy 0.000 description 39
- 230000008673 vomiting Effects 0.000 description 37
- 210000000952 spleen Anatomy 0.000 description 33
- 210000000214 mouth Anatomy 0.000 description 27
- 206010047700 Vomiting Diseases 0.000 description 23
- 208000001848 dysentery Diseases 0.000 description 21
- 206010012735 Diarrhoea Diseases 0.000 description 20
- 238000000034 method Methods 0.000 description 17
- 231100000614 poison Toxicity 0.000 description 16
- 235000020188 drinking water Nutrition 0.000 description 14
- 239000003651 drinking water Substances 0.000 description 14
- 210000004185 liver Anatomy 0.000 description 14
- 210000004916 vomit Anatomy 0.000 description 14
- 210000002966 serum Anatomy 0.000 description 12
- 241000700605 Viruses Species 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 210000002429 large intestine Anatomy 0.000 description 11
- 239000003440 toxic substance Substances 0.000 description 11
- 208000004232 Enteritis Diseases 0.000 description 10
- 210000003608 fece Anatomy 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 230000003340 mental effect Effects 0.000 description 10
- 208000035861 hematochezia Diseases 0.000 description 9
- 208000008071 Parvoviridae Infections Diseases 0.000 description 8
- 206010037660 Pyrexia Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 208000037920 primary disease Diseases 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000001142 anti-diarrhea Effects 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 206010057343 Parvovirus infection Diseases 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000000994 depressogenic effect Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010010947 Coordination abnormal Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 230000001047 pyretic effect Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 206010003591 Ataxia Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 description 4
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 208000016290 incoordination Diseases 0.000 description 4
- 230000002147 killing effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 239000003390 Chinese drug Substances 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000002155 anti-virotic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 235000013555 soy sauce Nutrition 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- CMCCHHWTTBEZNM-UHFFFAOYSA-N 2-bromo-N-carbamoyl-3-methylbutanamide Chemical compound CC(C)C(Br)C(=O)NC(N)=O CMCCHHWTTBEZNM-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 2
- 241000238659 Blatta Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000238661 Periplaneta Species 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000125945 Protoparvovirus Species 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000007950 acidosis Effects 0.000 description 2
- 208000026545 acidosis disease Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229960003880 bromisoval Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 208000013403 hyperactivity Diseases 0.000 description 2
- 230000000521 hyperimmunizing effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 2
- 229960004919 procaine Drugs 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 208000034579 Acute haemorrhagic conjunctivitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000195622 Astasia Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- 241000046998 Canine minute virus Species 0.000 description 1
- 241001032492 Canine parvovirus 2 Species 0.000 description 1
- 241000282470 Canis latrans Species 0.000 description 1
- 241001053849 Cerdocyon Species 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- 208000010772 Dog disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010059410 Faecaluria Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 241000282313 Hyaenidae Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000497005 Ixophorus unisetus Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000009525 Myocarditis Diseases 0.000 description 1
- 241001482564 Nyctereutes procyonoides Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000958485 Speothos venaticus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 231100000313 clinical toxicology Toxicity 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- ZBKIUFWVEIBQRT-UHFFFAOYSA-N gold(1+) Chemical compound [Au+] ZBKIUFWVEIBQRT-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000027909 hemorrhagic diarrhea Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000037805 labour Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002073 mitogenetic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides tablets for treating the canine parvovirus. The tablets are prepared from carbonized human hair, charred sophora flowers, honeysuckle flowers, coptis roots, cortex phellodendri, semen plantaginis, roots of Chinese pulsatilla, portulacae herba, hairyvein agrimonia herb and buds, red halloysite, rhizoma corydalis, poria cocos, red yeast rice, radix codonopsis, roasted rhizoma atractylodis macrocephalae, rhizoma atractylodis, oven earth, radix bupleuri, rhizoma cimicifugae and radix pueraiae. The tablets have a remarkable treatment effect on the canine parvovirus, reduce the death rate of diseased dogs and meanwhile improve the general condition of diseased dogs.
Description
Technical field
The present invention relates to technical field of Chinese medicine, particularly relate to a kind of tablet for treating Canine Parvovirus.
Background technology
Canine Parvovirus is that the Kelly and Canadian Thomson etc. of Australia in 1978 are simultaneously from the disease suffering from enteritis
Dog feces separates acquisition, from finding this virus so far, the most all has popular, be the topmost strong of harm dog class
One of infectious disease.The U.S., Britain, Germany, France, Italy, the state such as Russian and Japanese are found that this virus the most in succession.Serum
Learning investigation display, CPV positive serum can trace back to 1974-1976 the earliest in Europe;In the U.S., Canada, Japan and Australia
Big Leah can trace back to 1978.Superfine in order to be different from the dog being separated to from healthy dogs feces by Binn et al. 1967
Small virus (Minutevirusofcanine, MVC) (custom also on be called CPV-1) and by the viral nomenclature found later be
Canine Parvovirus 2 type (CPV-2).
CPV main infection dog, especially pup, infectiousness is extremely strong, and mortality rate is the highest.The most all can fall ill, with winter, spring
Multiple.Feeding and management condition cataclysm, long-distance transport, cold, crowded primary disease all can be promoted to occur.Sick dog is major source of infection, vomits
Anabole, saliva, feces all has a large amount of virus.Rehabilitation dog still can pass through the outside toxin expelling of feces for a long time.Evidence suggests people, louse,
Fly and Blatta seu periplaneta can become the mechanical carrier of CPV.Healthy dogs directly contacts with sick dog or band poison dog, or feedstuff through polluting and
Drinking-water passes through digestive tract infection.
Dog is main natural reservoir (of bird flu viruses), other Canis animalss, can also feel such as prairie wolf, Bushdog, Cerdocyon and hyena etc.
Dye.Along with virus antigen drifts about, virus can infect the animals such as cat, Little Bear, Nyctereutes procyonoides.
It is anxious that dog infects CPV morbidity, and mortality rate is high, normal break out and spread;All ages and classes, sex, the dog of kind all can be felt
Dye.Clinical manifestation is vomiting, diarrhoea (or hemorrhagic diarrhea) suffer from dog, CPV infects positive dog can account for 29.8-
46.2%.Wherein dog below 6 monthly ages is the most susceptible, and the ratio accounting for CPV infected dogs sum may be up to 75%, and this age in days section infects
It is high that dog mortality rate relatively larger than 6 monthly age suffers from dog;The most relatively low more than 12 monthly age dog sickness rate.Studies have found that, male dogs is more female
Property dog the most susceptible, but for suffering from dog less than 6 monthly ages, age, sex and kind infect to CPV do not have relevant.For 6-
18 the infected dogs survival rate researchs of week old CPV find, male and female between, between age groups, HI antibody titer < 1: 80
Group and 1: 160 group of significant difference.
Sick dog and recovery band poison dog are the sources of infection of primary disease.Sick dog is outwardly arranged through feces, urine, saliva and vomitus
Poison;Recovery band poison dog may pollute feedstuff, drinking-water, tableware and surrounding enviroment from the medium-term and long-term toxin expelling of fecaluria.And disease dog is generally in sense
Within after dye 7-8 days, peaked by feces toxin expelling, drastically reduce when 10-11 days.Evidence suggests, people, fly and Blatta seu periplaneta etc. are all
The mechanical carrier of CPV can be become.The route of infection that it is generally acknowledged this disease are digestive tract, and susceptible animal is mainly by directly or indirectly
Contact and infect.
Primary disease occurs without obvious seasonality.General summer, autumn seasonal prevalence.Cold weather, temperature cataclysm, sanitary condition
Difference and accompanying infection all can increase the weight of the state of an illness and improve mortality rate.
3-5 days incubation period of this disease, mostly occurring behind firm ring change border (pup as newly bought), have a bath, surfeit is inducement.This disease
Majority presents enteritis syndrome, and minority presents myocarditis syndrome.
Enteritis disease dog initial stage spirit is depressed, anorexia, accidental heating, soft stool or slightly vomit, and develops into subsequently and frequently vomits
Acutely suffer from diarrhoea in Tuhe.Originally feces gray, yellow or milky, band g., jelly-like mucus, discharge thereafter stench soy sauce sample or
Fructus Lycopersici esculenti juice sample of blood is just.Sick dog rapid dehydration, becomes thin, proscopiny, and in disorder by hair, skin is nonelastic, ear nose, coolness of extremities, essence
God is the most depressed, shock, dead.From disease, just symptom is slightly to being seriously usually no more than 2 days, and the whole course of disease is usually no more than one
Week.
Tentative diagnosis can be carried out clinically according to the cardinal symptom of routine blood test testing result and primary disease.Routine blood test detection is red carefully
Born of the same parents' hematocrit increases, and wbc value is normal or on the low side, often points out virosis.Sick dog excretion Fructus Lycopersici esculenti juice sample or soy sauce belt transect fishy odor
Hemafecia be the characteristic symptom of primary disease, can be as first visit foundation.
Using Canine Parvovirus gold colloidal quick diagnosis reagent paper to carry out the diagnosis of canine parvovirus disease more.This method is easy to be fast
Speed, accuracy rate is high.Dip the feces of disease dog with cotton swab or vomitus immerses and mixes equipped with in the plastic tube of normal saline, by 3~4
Drip supernatant drop in reagent paper reacting hole, stand 3~5min, as C and T corresponding position all occurs that red line is positive.
Find that primary disease should carry out isolated rearing immediately.Prevent disease dog from contacting with healthy dogs, to doghouse with sick dog breeders personnel
And place sterilizes repeatedly with 2% Caustic soda water or 10-20% bleaching powder etc..To remind especially, if your family once had, and this occurs
Sick doggie, even if environment is the most sterilized, also must not take other doggies not playing all vaccines, otherwise home again
Morbidity will soon be infected.
It is mainly symptomatic treatment clinically and coordinates hyper-immune serum and mab treatment.In a few days ago taboo that vomiting is serious
Food prohibits water, antiinflammatory in infusion process, stops blooding, correction acidosis, cooperation serum, anti-parvovirus monoclonal antibody, interferon etc.,
Until not vomitting, when not suffering from diarrhoea, the most heuristically feed light food.But its cure rate is relatively low, clinical efficacy is relatively
Difference.
Recently as the growth in the living standard of people, people raise the custom of dog class particularly pet dog increasingly
Many, the incidence rate of canine parvovirus disease is constantly mentioned, and people use the treatment means of doctor trained in Western medicine the most mostly, spends a large amount of
Money, curative effect is poor, and the misery born of pet dog is relatively big, and dog class and people are all mammal, for its function, disease
Pathological changes, the understanding of the side's of condemning medicine law can also apply corresponding theory of Chinese medical science to carry out direction of medication usage.It has recently been found that middle recurrence due to taking drug
There is clear and definite curative effect side for the treatment of canine parvovirus disease, and how to admix in dog food or drinking-water by Chinese medicine preparation, digestion
Road absorbs, and is possible not only to improve disease dog immunity, kill digestive tract virus, can improve disease dog clinical manifestation simultaneously, and the traditional Chinese medical science is recognized
For " depositing one point of gastric qi, just have a mitogenetic machine ", protecting the Gu of taste is a traditional Chinese medical science spotlight in animal medicine is put into practice and spy
Color.
Summary of the invention
The technical problem to be solved is to provide a kind of Chinese medicinal tablet for treating Canine Parvovirus, and it is to dog
Parvovirus therapeutic effect is notable, reduces sick dog case fatality rate, improves the ordinary circumstance of sick dog simultaneously.
For solving above-mentioned technical problem, the present invention provides a kind of medicine for treating Canine Parvovirus, its raw material medicated bag
Include charred Radix Sanguisorbae, charred Flos Sophorae, Flos Lonicerae, Rhizoma Coptidis, Cortex Phellodendri, Semen Plantaginis, the Radix Pulsatillae, Herba Portulacae, Herba Agrimoniae, Halloysitum Rubrum, Rhizoma Corydalis, Fu
Siberian cocklebur, Monas cuspurpureus Went, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Atractylodis, humus flava usta, Radix Bupleuri, Rhizoma Cimicifugae and Radix Puerariae.
Wherein, in described medicine, the weight portion of each crude drug is respectively charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 8 parts~12 parts, gold silver
Spend 13 parts~17 parts, Rhizoma Coptidis 20 parts, Cortex Phellodendri 10 parts~14 parts, Semen Plantaginis 13 parts~17 parts, the Radix Pulsatillae 13 parts~17 parts, Herba Portulacae
28 parts~32 parts, Herba Agrimoniae 28 parts~32 parts, Halloysitum Rubrum 8 parts~12 parts, Rhizoma Corydalis 28 parts~32 parts, 58 parts~62 parts of Poria,
18 parts~22 parts of Monas cuspurpureus Went, Radix Codonopsis 38 parts~42 parts, Rhizoma Atractylodis Macrocephalae (parched) 38 parts~42 parts, Rhizoma Atractylodis 18 parts~22 parts, humus flava usta 40 parts, Radix Bupleuri
6 parts~10 parts, Rhizoma Cimicifugae 6 parts~10 parts, Radix Puerariae 28 parts~32 parts.
Wherein, in described medicine, the weight portion of each crude drug is respectively charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 10 parts, Flos Lonicerae 15
Part, Rhizoma Coptidis 20 parts, Cortex Phellodendri 12 parts, Semen Plantaginis 15 parts, the Radix Pulsatillae 15 parts, Herba Portulacae 30 parts, Herba Agrimoniae 30 parts, Halloysitum Rubrum 10 parts,
Rhizoma Corydalis 30 parts, 60 parts of Poria, 20 parts of Monas cuspurpureus Went, Radix Codonopsis 40 parts, Rhizoma Atractylodis Macrocephalae (parched) 40 parts, Rhizoma Atractylodis 20 parts, humus flava usta 40 parts, Radix Bupleuri 8 parts,
Rhizoma Cimicifugae 8 parts, Radix Puerariae 30 parts.
Wherein, described medicine is prepared as tablet.
The preparation method of described tablet particularly as follows:
The first step, pulverizes each crude drug respectively, mixes, use water extraction;
Second step, extracting solution concentrates, it is thus achieved that the effective extract component of medicine;
3rd step, second step obtain the effective extract component of medicine mix homogeneously according to the mass ratio of 3: 2 with starch, then
Adding excipients magnesium stearate, the addition of magnesium stearate is the 5% of starch and effective extract component mixing quality sum, compacting
In flakes, it is thus achieved that tablet.
Wherein, the described first step is specially further and is pulverized respectively by each crude drug, mixes, adds mixture quality
The water boil of 10 times, maintains 2 hours, filters, and filtering residue adds the water boil of mixture quality 6 times again, maintains 1 hour, filters, two
Secondary filtrate mixes, and concentrates for second step.
Wherein, described second step is that the hybrid filtering liquid first step obtained concentrates further, it is thus achieved that 60 DEG C of relative densities
The mastic of 1.25, for the 3rd step.
Useful technique effect
The Chinese medicinal tablet for treating Canine Parvovirus that the present invention provides, it is notable to Canine Parvovirus therapeutic effect,
Reduce sick dog case fatality rate, improve the ordinary circumstance of sick dog simultaneously.
Detailed description of the invention
Canine parvovirus infection is to annoying people pet feeding dog at present and plant the disease that dog base cultivates in a large number, ill
Dog class mortality rate is higher.It is mainly symptomatic treatment clinically and coordinates hyper-immune serum and mab treatment.Serious in vomiting
A few days ago water, antiinflammatory in infusion process are prohibited in fasting, stop blooding, correction acidosis, cooperation serum, anti-parvovirus monoclonal antibody,
Interferon etc., until not vomitting, the most heuristically feed light food when not suffering from diarrhoea.But its cure rate is relatively low, faces
Bed curative effect is poor.
We are through carrying out clinical research discovery, based on enteritis syndrome after morbidity to a large amount of ill dog classes.Enteritis disease
Dog initial stage spirit is depressed, anorexia, accidental heating, soft stool or slightly vomit, and develops into frequently vomiting and violent diarrhoea subsequently.Rise
Just feces gray, yellow or milky, band g., jelly-like mucus, discharge thereafter the soy sauce sample of stench or Fructus Lycopersici esculenti juice sample of blood just.Sick
Dog rapid dehydration, becomes thin, and proscopiny is in disorder by hair, and skin is nonelastic, ear nose, coolness of extremities, and spirit is the most depressed, shock,
Dead.From disease, just symptom is slightly to being seriously usually no more than 2 days, and the whole course of disease is usually no more than one week.
Dog is Mammalia Carnivora Canidae Canis animal, and Chinese medicine is long-standing for the use of dog class, and beast in ancient times
Doctor and modern veterinary development find, the disease of dog and medication can combine with theory of Chinese medical science completely.For doctor trained in Western medicine for
Canine parvovirus infection is without good Therapeutic Method, and the use of Chinese medicine brings hope to undoubtedly the healing of this disease.To ill dog
Carrying out dialectical analysis, this disease is hemorrhagic enteritis, is classified as distemper epidemic disease, fall ill hurried, generate heat, suffer from abdominal pain, abdominal distention, vomiting, under
The hemafecia that dysentery corruption is stench is main performance.Treatment is when heat-clearing and toxic substances removing, cooling blood for hemostasis, yang invigorating antidiarrheal, drying damp and strengthening spleen.
The present invention provides a kind of medicine for treating Canine Parvovirus, and its crude drug is by charred Radix Sanguisorbae, charred Flos Sophorae, gold silver
Flower, Rhizoma Coptidis, Cortex Phellodendri, Semen Plantaginis, the Radix Pulsatillae, Herba Portulacae, Herba Agrimoniae, Halloysitum Rubrum, Rhizoma Corydalis, Poria, Monas cuspurpureus Went, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched),
Rhizoma Atractylodis, humus flava usta, Radix Bupleuri, Rhizoma Cimicifugae and Radix Puerariae are constituted.
The present invention is with charred Radix Sanguisorbae, Rhizoma Coptidis, humus flava usta three medicine for core medication, and charred Radix Sanguisorbae is bitter, sour, puckery, is slightly cold, return Liver Channel,
Large intestine channel, has cooling blood for hemostasis, effect of removing toxic substances sore, clinical for having blood in stool, hemorrhoidal bleeding, dysentery, metrorrhagia, burn due to hot liquid or fire, carbuncle
Sores etc. have well effect, the particularly traditional Chinese medical science to think " blood obtains black, stops ", strengthen its removing toxic substances and hold back effect of wound hemostasis after parch to black;
Rhizoma Coptidis has heat clearing and damp drying, effect of eliminating fire and detoxication, is clinically used for damp and hot feeling of fullness, vomits acid regurgitation, dysentery, jaundice, unconsciousness due to high fever,
Hyperactivity of heart-fire, dysphoria and insomnia, heat in blood tells nosebleed, conjunctival congestion, and toothache is quenched one's thirst, and carbuncle furuncle, Rhizoma Coptidis soothing liver-QI stomach function regulating preventing or arresting vomiting, is used for simultaneously
Incoordination between the liver and stomach, vomits acid regurgitation, and the treatment for primary disease is i.e. verified, suited the medicine to the illness again, is the treatment of disease combination, modern medicine study
In Rhizoma Coptidis, effective ingredient has significant antibacterial action, antivirus action, ameba is also had to good inhibiting effect,
Additionally, Rhizoma Coptidis can also antiinflammatory, health diarrhoea, after acting on disease dog, blood circulation can be had well regulate work with antipyretic-antalgic
With;Using humus flava usta to have cough-relieving inverse, hemostasis, effect of subduing inflammation poison, because charred Radix Sanguisorbae, Rhizoma Coptidis is cold medicine, is anti-
Only the coolest gripping, therefore add and not only can stop blooding with spleen invigorating, but also can help its cold humus flava usta of system, using medicines of both cold and hot natures simultaneously, malicious heresy can be gone, dysentery can
Puckery, hematochezia can stop, and in the hope of effect of fullying recover from an illness, it is monarch drug group altogether that three medicines share, and we have also been made relevant research for monarch drug consumption, Radix Sanguisorbae
Charcoal: Rhizoma Coptidis: when humus flava usta is 1: 1: 2, its best results, if reducing the consumption of charred Radix Sanguisorbae, then hemostatic function weakens, if reducing Huang
The amount of being used in conjunction, then there will be anti-diarrhea effect and lower, and antivirus action weakens, if reducing the consumption of humus flava usta, then warming the meridian for stopping bleeding is made
With reduction, increase relative to cold and cool medicine ratio, have cool gripping, close door and stay Kou Zhizhuan, if reducing charred Radix Sanguisorbae, the consumption of Rhizoma Coptidis, i.e.
The consumption of humus flava usta increases relatively, then have and significantly help heat effect, with the method for the treatment of phase of the traditional Chinese medical science " treating heat syndrome with cold-natured drugs, treating cold syndrome with hot-nature drugs "
The back of the body, it is impossible to quick-acting.Addition charred Flos Sophorae, the Radix Pulsatillae, Herba Portulacae three medicine coordinate with monarch drug charred Radix Sanguisorbae, Flos Sophorae bitter in the mouth, and property is put down, nontoxic,
There is effect of heat clearing away, removing heat from blood, hemostasis, blood pressure lowering.Parch to black uses herein, strengthens its removing heat from blood, hemostasia effect, and this medicine has preferably simultaneously
Anthelmintic action, strengthen blood capillary resistance, reduce vascular permeability, have good therapeutical effect for hemorrhage;Dens Equi
Herba Amaranthi tricoloris has good therapeutical effect for all kinds of enteritis, dysentery etc., can be with heat-clearing and toxic substances removing, parasite killing only profit;Hoary hair has asked very well
Effect of heat-clearing and toxic substances removing, be usually used in the symptoms such as lower profit band blood, there is the effect of good antioxidation, antiinflammatory, have parasite killing simultaneously
Bacteriostasis efficacy, coordinates monarch drug charred Radix Sanguisorbae clearing away heat and cooling blood, hemostasis only profit, addition Flos Lonicerae, Cortex Phellodendri, Semen Plantaginis to coordinate monarch drug Rhizoma Coptidis dry
Dairrhea caused by pathogenic damp fire, heat-clearing and toxic substances removing, dampness removing only profit, modern medicine study, Flos Lonicerae antiinflammatory, antivirus action are obvious, not only body animal
Experiment has well effect, and antibacterial, virus for isolated culture also have killing action, Rhizoma Coptidis, Cortex Phellodendri, Semen Plantaginis, the Radix Pulsatillae
Four medicines share bitter cold sedimentation, heat clearing and damp drying, effect of eliminating fire and detoxication, return kidney channel, bladder warp, can be descending with heat conduction, diuresis
With real stool, add the medicines such as Halloysitum Rubrum, Poria, Monas cuspurpureus Went, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched), Rhizoma Atractylodis, coordinate monarch drug humus flava usta only to play warming the meridian altogether
Blood, dampness removing and diarrhea-relieving, strong the spleen governs the blood, wherein Halloysitum Rubrum sweet in the mouth, acid, puckery, warm in nature, there are astringing intestine to stop diarrhea, hemostasia effect, especially for this disease
Under middle and late stage, profit pus and blood has good therapeutical effect, addition Poria, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched) tonification lung spleen, spleen invigorating to help fortune, play very well
Anti-diarrhea effect, the spleen governs the blood, the strong fortune of temper then system blood has the right, and The spleen and stomach provide the material basis of the acquired simultaneously, deposits to obtain a gastric qi, just has portion
Life, three medicines share, and it will be congenital to support for the day after tomorrow to play benefit altogether, and QI and blood is biochemical active, and whole body healthy energy fills Sheng, it is possible to anti-heresy is gone out, all medicines
Share, be ministerial drug altogether;Add a small amount of Monas cuspurpureus Went, have good spleen invigorating to help running use, but Chinese medicine preparation of the present invention is more importantly
Promote the function of becoming thoroughly decomposed of stomach with Monas cuspurpureus Went, regulate effect of archenteric flora, the enteritis caused after virus or antibacterial are infected,
Sick dog vomiting, have loose bowels after, alteration of intestinal flora, its therapeutic effect is especially notable, and retention of water-damp within middle-JIAO is one of reason of vomiting, tells
Rushing down and determine without complete gas afterwards, Rhizoma Atractylodis coordinate with Rhizoma Atractylodis Macrocephalae (parched), Poria two medicine, play drying damp and strengthening spleen, stomach function regulating removing dampness effect altogether, add a small amount of celestial
Crane grass, has the wet effect in the most sharp blood, adds Rhizoma Corydalis regulating QI to relieve pain, blood-activating and qi-promoting, and sick dog cannot use language and the mankind
Exchange, however we it is envisioned that people obtained the disease such as dysentery, enteritis time, many abdominal pain diarrheas, vomiting etc., therefore, this
Invention Chinese medicine preparation adds Rhizoma Corydalis, plays analgesic efficacy, and not available for other prescriptions, all medicines share as adjuvant drug;Additionally, it is clear
Gas, lower, gives birth to lientery, and Chinese medicine preparation of the present invention adds a small amount of Radix Bupleuri, Rhizoma Cimicifugae, Radix Puerariae yang invigorating antidiarrheal, for Radix Bupleuri, the use of Rhizoma Cimicifugae
Amount is strict controlled in below 10 weight portions, and heavy dose of use is then without yang invigorating antidiarrheal efficacy, and it is cloudy that a large amount of use Radix Bupleuri also can consume impairing the liver,
Add the Radix Puerariae of larger dose, be possible not only to yang invigorating antidiarrheal, and have promoting the production of body fluid to quench thirst effect, vomit, have loose bowels and the most serious be exactly
Dehydration, after using Radix Puerariae, can maintain blood volume, and the first aid for sick dog has a very important role.
In sum, Chinese medicine preparation of the present invention has the effect well treating Canine parvovirus infection dog class, and leads to
Clinical research and experimentation are crossed it was confirmed its curative effect, it is adaptable to larger range of promote the use of.
In described medicine, the weight portion of each crude drug is respectively charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 8 parts~12 parts, Flos Lonicerae 13 parts
~17 parts, Rhizoma Coptidis 20 parts, Cortex Phellodendri 10 parts~14 parts, Semen Plantaginis 13 parts~17 parts, the Radix Pulsatillae 13 parts~17 parts, Herba Portulacae 28 parts~
32 parts, Herba Agrimoniae 28 parts~32 parts, Halloysitum Rubrum 8 parts~12 parts, Rhizoma Corydalis 28 parts~32 parts, 58 parts~62 parts of Poria, Monas cuspurpureus Went 18
Part~22 parts, Radix Codonopsis 38 parts~42 parts, Rhizoma Atractylodis Macrocephalae (parched) 38 parts~42 parts, Rhizoma Atractylodis 18 parts~22 parts, humus flava usta 40 parts, Radix Bupleuri 6 parts~
10 parts, Rhizoma Cimicifugae 6 parts~10 parts, Radix Puerariae 28 parts~32 parts.
Most preferably, in described medicine, the weight portion of each crude drug is further preferably respectively charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 10
Part, Flos Lonicerae 15 parts, Rhizoma Coptidis 20 parts, Cortex Phellodendri 12 parts, Semen Plantaginis 15 parts, the Radix Pulsatillae 15 parts, Herba Portulacae 30 parts, Herba Agrimoniae 30 parts,
Halloysitum Rubrum 10 parts, Rhizoma Corydalis 30 parts, 60 parts of Poria, 20 parts of Monas cuspurpureus Went, Radix Codonopsis 40 parts, Rhizoma Atractylodis Macrocephalae (parched) 40 parts, Rhizoma Atractylodis 20 parts, humus flava usta 40
Part, Radix Bupleuri 8 parts, Rhizoma Cimicifugae 8 parts, Radix Puerariae 30 parts.
Each crude drug pharmacology is as follows:
Charred Radix Sanguisorbae: for the Preparation process product of Radix Sanguisorbae, bitter in the mouth, acid, puckery, cold nature, return liver, large intestine channel, there is cooling blood for hemostasis,
The cards such as effect of removing toxic substances sore, cures mainly and have blood in stool, hemorrhoidal bleeding, dysentery, metrorrhagia, burn due to hot liquid or fire, carbuncle sore tumefacting virus.
Charred Flos Sophorae: bitter in the mouth, cool in nature, return liver, large intestine channel, there is heat clearing away, removing heat from blood, effect of hemostasis, cure mainly discharging fresh blood stool, hemorrhoid
Blood, hematuria, stranguria with blood, metrorrhagia, epistaxis, under dysentery with red and white feces, wind heat conjunctival congestion, skin sore, prevention of stroke etc. is demonstrate,proved.
Flos Lonicerae: latin name lonicerae japonicae flos, sweet in the mouth, cold in nature, enter the heart, lung, stomach, large intestine channel, have
The effect of heat-clearing and toxic substances removing, holding concurrently can eliminating pathogenic heat from blood to cure dysentery.Be mainly used in affection due to external wind and heat, epidemic febrile disease pyretic toxicity is relatively contained, or epidemic febrile disease is from the beginning of pathogenic heat still
At the part of the body cavity above the diaphragm housing the heart and lungs the most descending time;Pyretic toxicity dysentery, stool hematochezia;Fever disease in summer is demonstrate,proved.
Rhizoma Coptidis: bitter in the mouth, cold in nature, enters the heart, lung, gallbladder, stomach, large intestine channel, has the work of heat clearing and damp drying, eliminating fire and detoxication, cooling blood for improving eyesight
With, it is longer than the fire of removing pathogen in the heart warp, can be used for treating the prosperous caused dysphoria and insomnia of heart-fire, and the high fever coma of epidemic febrile disease, vexed, mouth
Yearningly;Can be additionally used in damp and hot caused dysentery, tenesmus;Pyretic toxicity carbuncle sore, eczema, aphtha of the mouth and tongue, epidemic hemorrhagic conjunctivitis etc. are demonstrate,proved.
Cortex Phellodendri: bitter in the mouth, cold in nature, return kidney, bladder, large intestine channel, there is heat clearing and damp drying, effect of eliminating fire and detoxication.Cure mainly damp and hot
Dysentery, jaundice, leukorrhagia, pyretic stranguria, tinea pedis, flaccidity wards off, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus, hyperactivity of fire caused by deficiency of YIN,
Night sweat hectic fever due to YIN-deficiency etc. are demonstrate,proved.
The Radix Pulsatillae: bitter in the mouth, cold in nature, enters stomach, large intestine channel, has heat-clearing and toxic substances removing, and the effect of eliminating pathogenic heat from blood to cure dysentery is mainly used in gastrointestinal
Having damp and hot stagnant heating stomachache, dysentery pus and blood, tenesmus etc. is demonstrate,proved.
Herba Portulacae: latin name Portulacae herba, sour in the mouth, cold in nature, return large intestine, Liver Channel, there is heat-clearing and toxic substances removing, diuretic
Drying, dissipate blood detumescence, dust-collection sterilization, anti-inflammatory analgetic, effect of hemostasis removing heat from blood, cure mainly dysentery, enteritis, nephritis, puerperal, uterus went out
The diseases such as blood, has blood in stool, mastitis.
Herba Agrimoniae: latin name Agrimoniae Herba, bitter in the mouth, puckery, property is put down, and GUIXIN, Liver Channel have astringing to arrest bleeding, only
Effect of dysentery parasite killing, cures mainly various hemorrhage card, such as: haematemesis, hematuria, have blood in stool, metrorrhagia, spitting of blood, epistaxis, dysentery, labor
The de-power of wound, carbuncle, traumatic injury, wound hemorrhage etc. is demonstrate,proved.
Halloysitum Rubrum: sweet in the mouth, acid, puckery, warm in nature, to return large intestine, stomach warp, there is astringing intestine to stop diarrhea, hemostasis, promoting tissue regeneration and ulcer healing effect, for for a long time
Rush down chronic dysentery, fecal blood, bleeding not during menses;The cards such as external treatment skin infection is burst for a long time and do not held back, eczema pus contamination.
Rhizoma Corydalis: acrid in the mouth, hardship, warm in nature, enter liver, spleen channel, there is promoting blood circulation to remove blood stasis, the effect of promoting the circulation of QI to relieve pain, for stagnation of QI blood
The various pains card that the stasis of blood causes, particularly trusted subordinate's pain is commonly used, and such as depressed liver and heat transmission, the gastral cavilty abdominal distention of incoordination between the liver and stomach, has analgesic
Effect.
Poria: sweet in the mouth, light, property is put down, is entered the heart, lung, spleen, kidney channel, have eliminating dampness and diuresis, the effect of spleen invigorating mind calming, be mainly used in
The edema of retention of water-damp, dysuria;The pyretic stranguria of damp-heat accumulation, the stagnation of the anorexia and loose stool of stagnation of dampness due to deficiency of the spleen, phlegm retention, epilepsy etc. are demonstrate,proved.
Monas cuspurpureus Went: latin name Fermentum Rubrum, sweet in the mouth, warm in nature, return liver, spleen, stomach, large intestine channel, there is blood circulation promoting and blood stasis dispelling;
Effect of strengthening the spleen to promote digestion.Cure mainly eating accumulation;Distension and fullness in the abdomen;Red white dysentery;Prolonged lochia;Traumatic injury etc. are demonstrate,proved.
Radix Codonopsis: sweet in the mouth, property is flat, returns lung, spleen channel, has QI invigorating strengthening the spleen, and effect of nourishing blood to promote the production of body fluid cures mainly deficiency of both the splenic and pulmonary QI or gas
The fatigue and weakness of blood two void, breathing hard, the symptom such as cough spontaneous perspiration, Radix Codonopsis is longer than spleen reinforcing nourishing the stomach, adjusts regulating the function of middle-JIAO, has the work nourished blood concurrently
Put down by, its property, spleen invigorating fortune and the driest;Flavour is cloudy and the wettest, it is possible to improves the immune state of body, improves resistance against diseases.
Rhizoma Atractylodis Macrocephalae (parched): sweet in the mouth, hardship, warm in nature, enter spleen, stomach warp, have spleen reinforcing promoting the circulation of QI, dampness diuretic, strengthening superficial resistance to stop perspiration, activating the spleen is moisturized
Effect, is mainly used in the feeling of fullness diarrhoea caused by dysfunction of the spleen in transportation, QI failing to transform into body fluid, phlegm retention edema;The vexed lazy speech of deficiency of QI in middle-JIAO, metrorrhagia
Leak down, proctoptosis with chronic dysentery;The card such as solid, sweating due to debility spontaneous perspiration in the playing of deficiency of the spleen causing weakness of QI.
Rhizoma Atractylodis: acrid in the mouth, hardship, warm in nature, enter spleen, stomach, Liver Channel, have drying damp and strengthening spleen, expelling wind and dampness, the effect of improving eyesight, mainly use
In the stomachache dysentery of retention of dampness in middle-JIAO, the abdominal distention pain of incoordination between the spleen and stomach, vomit indigestion and loss of appetite;The abdomen side of body distending pain, the vomiting with acid regurgitation of incoordination between the liver and stomach;
And the card such as the anemofrigid-damp arthralgia of the outer strongly fragrant meridians of cold-damp.
Humus flava usta: acrid in the mouth, slightly warm in nature, return spleen, stomach warp, there is warming middle-JIAO for easing the stomach, preventing or arresting vomiting, hemostasis, effect of antidiarrheal.Cure mainly spleen
The cards such as insufficiency of stomach is trembled with fear, and vomiting is felt sick, and spits blood, epistaxis, and hematuria is had blood in stool, metrorrhagia, insufficiency of the spleen chronic diarrhea.
Radix Bupleuri: latin name bupleuri radix, for umbelliferae bupleurum or the dry root of Radix Bupeuri Scorzonerfolii., bitter in the mouth, property
It is slightly cold, returns liver, gallbladder meridian, there is evacuation and bring down a fever, effect of yang invigorating soothing liver-QI, cure mainly cold, fever, alternate attack of chill and fever, malaria, stagnation of liver-QI gas
Stagnant, sternal rib pain, proctoptosis, the cards such as uterus comes off, menoxenia.
Rhizoma Cimicifugae: acrid in the mouth, micro-sweet, cold nature, enter lung, spleen, stomach, large intestine channel, have and deliver rash, heat-clearing and toxic substances removing, rise and lift sun
Effect of gas.For headache due to pathogenic wind-heat, toothache, aphtha, laryngopharynx swelling and pain, measles without adequate eruption, YANG toxin syndrome sends out speckle;Proctoptosis, uterine prolapse etc. is demonstrate,proved.
Radix Puerariae: latin name Puerariae Lobatae Radix, sweet in the mouth, pungent, cool in nature, enter spleen, stomach warp, have inspiration gastric qi,
Clearing away heat and promoting production of body fluid, expelling pathogenic factors from muscles is delivered, raw positive, oozes the effect of rash, is mainly used in fever caused by exogenous pathogens, and headache, stiff nape and back, calentura is thirsty, disappears
Yearningly;Diarrhea due to hypofunction of the spleen, clear YANG failing to ascend etc. is demonstrate,proved.
The medicine that the present invention provides can be prepared as tablet or powder, is preferably prepared to tablet.
The preparation method of described tablet particularly as follows:
The first step, pulverizes each crude drug respectively, mixes, use water extraction;
Second step, extracting solution concentrates, it is thus achieved that the effective extract component of medicine;
3rd step, second step obtain the effective extract component of medicine mix homogeneously according to the mass ratio of 3: 2 with starch, then
Adding excipients magnesium stearate, the addition of magnesium stearate is the 5% of starch and effective extract component mixing quality sum, compacting
In flakes, it is thus achieved that tablet.
The described first step is specially further and is pulverized respectively by each crude drug, mixes, adds mixture quality 10 times
Water boil, maintain 2 hours, filter, filtering residue adds the water boil of mixture quality 6 times again, maintains 1 hour, filtration, twice mistake
Filtrate mixes, and concentrates for second step.
Described second step is that the hybrid filtering liquid first step obtained concentrates further, it is thus achieved that 60 DEG C of relative densities 1.25
Mastic, for the 3rd step.
Embodiment is below used to describe embodiments of the present invention in detail, whereby to the present invention how application technology means
Solve technical problem, and the process that realizes reaching technique effect can fully understand and implement according to this.
Embodiment 1 tablet 1
By charred Radix Sanguisorbae 20g, charred Flos Sophorae 10g, Flos Lonicerae 15g, Rhizoma Coptidis 20g, Cortex Phellodendri 12g, Semen Plantaginis 15g, Radix Pulsatillae 15g,
Herba Portulacae 30g, Herba Agrimoniae 30g, Halloysitum Rubrum 10g, Rhizoma Corydalis 30g, Poria 60g, Monas cuspurpureus Went 20g, Radix Codonopsis 40g, Rhizoma Atractylodis Macrocephalae (parched) 40g, grey
Art 20g, humus flava usta 40g, Radix Bupleuri 8g, Rhizoma Cimicifugae 8g, Radix Puerariae 30g pulverize respectively, mix, and add the water boil of 4.7kg, maintain
2 hours, filtering, filtering residue adds the water boil of 3kg again, maintains 1 hour, filters, twice filtrate mixing, concentrates, it is thus achieved that 60 DEG C
The mastic of relative density 1.25, takes mastic 300g and mixs homogeneously with starch 200g, adds excipients magnesium stearate 25g, compacting
In flakes, it is thus achieved that tablet 1,0.5g/ sheet.
Comparative example 1 tablet 2
By charred Radix Sanguisorbae 10g, charred Flos Sophorae 10g, Flos Lonicerae 15g, Rhizoma Coptidis 10g, Cortex Phellodendri 12g, Semen Plantaginis 15g, Radix Pulsatillae 15g,
Herba Portulacae 30g, Herba Agrimoniae 30g, Halloysitum Rubrum 10g, Rhizoma Corydalis 30g, Poria 60g, Monas cuspurpureus Went 20g, Radix Codonopsis 40g, Rhizoma Atractylodis Macrocephalae (parched) 40g, grey
Art 20g, humus flava usta 40g, Radix Bupleuri 8g, Rhizoma Cimicifugae 8g, Radix Puerariae 30g pulverize respectively, mix, and add the water boil of 4.7kg, maintain
2 hours, filtering, filtering residue adds the water boil of 3kg again, maintains 1 hour, filters, twice filtrate mixing, concentrates, it is thus achieved that 60 DEG C
The mastic of relative density 1.25, takes mastic 300g and mixs homogeneously with starch 200g, adds excipients magnesium stearate 25g, compacting
In flakes, it is thus achieved that tablet 2,0.5g/ sheet.
Comparative example 2 tablet 3
By charred Radix Sanguisorbae 20g, charred Flos Sophorae 10g, Flos Lonicerae 15g, Rhizoma Coptidis 20g, Cortex Phellodendri 12g, Semen Plantaginis 15g, Radix Pulsatillae 15g,
Herba Portulacae 30g, Herba Agrimoniae 30g, Halloysitum Rubrum 10g, Rhizoma Corydalis 30g, Poria 60g, Monas cuspurpureus Went 20g, Radix Codonopsis 40g, Rhizoma Atractylodis Macrocephalae (parched) 40g, grey
Art 20g, humus flava usta 20g, Radix Bupleuri 8g, Rhizoma Cimicifugae 8g, Radix Puerariae 30g pulverize respectively, mix, and add the water boil of 4.7kg, maintain
2 hours, filtering, filtering residue adds the water boil of 3kg again, maintains 1 hour, filters, twice filtrate mixing, concentrates, it is thus achieved that 60 DEG C
The mastic of relative density 1.25, takes mastic 300g and mixs homogeneously with starch 200g, adds excipients magnesium stearate 25g, compacting
In flakes, it is thus achieved that tablet 3,0.5g/ sheet.
Toxicological study
Because the dog class disease that Canine parvovirus infection causes, its clinical onset has own characteristic, from morbidity to dead one
As less than one week, therefore, the medicine for treatment for this disease also gets a grip on time window, and medication was less than 7 days.In order to verify
The clinical drug safety of Chinese medicinal tablet of the present invention, therefore set up anxious toxicity test, probe in 7 days, take in a large number in the present invention
Whether the sick dog of tablet there will be clinical toxicity.
Animal origin: certain dog base, Dezhou, Shandong is uninfected by tiny dog 20, kind, weight, sex
Ask.
Experimental drug: the tablet 1 of the embodiment of the present invention 1 preparation, 0.5g/ sheet, containing Effective Component of Chinese Medicine 0.3g/ sheet.
Packet is administered:
Experimental group: admix after being ground by tablet 1 in dog feed, calculates according to Canis familiaris L. daily ingestion of dog food weight, every dog
Taking in Effective Component of Chinese Medicine of the present invention is 55g/kg/d, is equivalent to be clinically used for the dosage (2.4g/kg/d) of disease dog
22.92 times.
Matched group: give experimental group same with equivalent starch, medication and dosage, be administered 7 days, observes corresponding index.
Observation index: observing death condition during medication, daily inleting appetite every to dog, amount of drinking water carry out statistical analysis, to dog
The mental status, two just situation carry out perusal, and do itemized record.
Result: by the dog medication anxious Toxicity Observation of 7 days, dead without dog, for dog class diet, drinking-water, the mental status,
The observation of two just situations, two groups of dogs are without marked difference;Two groups of dog body weight change values are compared, takes Chinese medicine system of the present invention
The experimental group dog of agent, its body weight value added is significantly higher than matched group, and the Chinese medicinal tablet of the present invention increase for dog class body weight is described
There are remarkable effect, P < 0.05.Because this medicine not effect on human body, therefore dosage uses own control, i.e. dosage meeting
On the basis of convention, exceed well over conventional amount used, be i.e. considered heavy dose of administration.
By above-mentioned experimental verification, Chinese medicinal tablet of the present invention is without obvious toxic-side effects.Related Experimental Study can be carried out.
Experimentation
Sick dog source: the parvovirus infections dog 93 that pet clinic of Qingdao City is medical, to dog age, sex, kind of dog without
Requirement, unification is included.
Packet and medication: sign clinical application agreement with dog owner, dog of just diagnosing a disease has during 44 people are ready to use and cures
Treatment mode, includes Chinese drug-treated group in, and remaining is western medical treatment method, includes Western medicine group in.
Chinese drug-treated group: this group disease dog uses the Chinese medicinal tablet 1 of the embodiment of the present invention 1 preparation, disease preferable for ordinary circumstance
Dog, uses Chinese medicinal tablet levigation, is added in disease dog feed and drinking-water, it is ensured that sick dog reaches for the crude drug intake of Chinese medicine
4g/kg/d, medicine time is multiple dosing, not limiting time;For the sick dog that ordinary circumstance is poor, use stomach tube medication,
0.5 centimetre of cut-off footpath, the thin plastic pipe of long 40 centimetres are as stomach tube.After opening oral cavity, insert stomach tube, extract medicinal liquid with syringe
Inject stomach tube.Owing to dog has vomiting habit, after extraction stomach tube after 3~5 minutes, common medicinal liquid spues, must after a few minutes of interval again
Gavage once by same method, through twice throwing clothes lose vomiting more, it is ensured that day dosage be 4g/kg/d.Sending out according to this disease
Sick rule, treatment cycle is 7 days.
Western medicine group: the sick refined 5-linked serum of dog injection combines love Mao Er (bromisoval procaine), for ordinary circumstance relatively
Good sick dog, refined 5-linked serum injection amount is 1ml/kg, 1 times/day, likes that your injection volume of cyclopentadienyl is 2ml/ time, 1 times/day, to diet
And drinking-water does not processes;For the sick dog that ordinary circumstance is poor, refined 5-linked serum injection amount is 2ml/kg, 1 times/day, likes cyclopentadienyl
Your injection volume is 2ml/ time, 2 times/day, does not processes diet and drinking-water;According to the occurrence regularity of this disease, treatment cycle is 7
My god.
Observation index: after administration, observe dog diet, drink water, vomit, two just situations, observe the mental status of dog simultaneously.Right
In dying of illness, dog is analysed, and observes the change of each internal organs.
Result:
Sick dog treatment situation
Table 1 sick dog treatment situation
Group | N | Recovery from illness | Effectively | Die of illness | Cure rate | Mortality rate |
Treatment group | 44 | 22 | 17 | 5 | 50.00%* | 11.36%* |
Matched group | 49 | 9 | 19 | 21 | 18.37% | 42.86% |
Compare with matched group,*P < 0.05
By sick dog is treated the comparison of situation, the cure rate of Chinese medicinal tablet of the present invention is significantly higher than western medicine group P
< 0.05, mortality rate is substantially less than matched group P < 0.05 simultaneously.
Sick dog ordinary circumstance
For dead sick dog, carry out ordinary circumstance observation, observe dog diet, drink water, vomit, two just situations, see simultaneously
Examine the mental status of dog.
The ordinary circumstance of the not dead sick dog of table 2
Group | N | Diet increases | Drinking-water increases | Vomiting reduces | Two is the most normal | Mental status amelioration |
Chinese drug-treated group | 39 | 33 | 36 | 29* | 30* | 36* |
Doctor trained in Western medicine group | 28 | 24 | 25 | 13 | 16 | 22 |
Compare with doctor trained in Western medicine group,*P < 0.05
By the dog that do not dies of illness is carried out ordinary circumstance observation, improve in vomiting, two just the changing of condition improved and mental status
On Shan, treatment group is significantly better than matched group, P < 0.05.
From the above it can be seen that Chinese medicinal tablet of the present invention has for the sick dog of Canine parvovirus infection well treats work
With, reduce sick dog case fatality rate, improve the ordinary circumstance of sick dog simultaneously.There is good using value.
Experimentation
Sick dog source: certain dog base parvovirus infections dog 83 of Dezhou, Shandong.
Clinical manifestation: primary disease is general without advanced symptoms, many sudden onset.Mainly show as serious gastroenteritis haemorrhagica disease
Shape, i.e. vomits, suffers from diarrhoea, arranges band bloody stool and be just dehydrated with body, and apparent altitude is depressed simultaneously, and appetite is useless absolutely, astasia, body temperature liter
Up to 40 DEG C~41 DEG C, but the body temperature that general adult dogs has is the highest, suffers from diarrhoea the most sustainable about one week.Leukocyte count is obvious
Reduce, have to drop to 3000/mm3 such as the following.
Packet is administered: disease dog is divided into 4 groups, is invention group 21 respectively, comparative example 1 group 21, comparative example 2 groups 21,
Western medicine group 20.
Invention group: this group disease dog uses the Chinese medicinal tablet 1 of the embodiment of the present invention 1 preparation, disease preferable for ordinary circumstance
Dog, uses Chinese medicinal tablet levigation, is added in disease dog feed and drinking-water, it is ensured that sick dog reaches 4g/kg/ for the intake of Chinese medicine
D, medicine time is multiple dosing, not limiting time;For the sick dog that ordinary circumstance is poor, use stomach tube medication, cut-off footpath
0.5 centimetre, the thin plastic pipe of long 40 centimetres is as stomach tube.After opening oral cavity, insert stomach tube, inject stomach with syringe extraction medicinal liquid
Pipe.Owing to dog has vomiting habit, after extraction stomach tube after 3~5 minutes, common medicinal liquid spues, must be again with equally after a few minutes of interval
Method gavage once, through twice throwing clothes lose vomiting more, it is ensured that day dosage be 4g/kg/d.According to the occurrence regularity of this disease,
Treatment cycle is 7 days.
Comparative example 1 group: this group disease dog uses the Chinese medicinal tablet 2 of comparative example 1 of the present invention preparation, preferable for ordinary circumstance
Sick dog, uses Chinese medicinal tablet levigation, is added in disease dog feed and drinking-water, it is ensured that sick dog reaches 4g/ for the intake of Chinese medicine
Kg/d, medicine time is multiple dosing, not limiting time;For the sick dog that ordinary circumstance is poor, use stomach tube medication, cut-off
0.5 centimetre of footpath, the thin plastic pipe of long 40 centimetres are as stomach tube.After opening oral cavity, insert stomach tube, inject with syringe extraction medicinal liquid
Stomach tube.Owing to dog has vomiting habit, after extraction stomach tube after 3~5 minutes, common medicinal liquid spues, must be again with same after a few minutes of interval
The method of sample gavages once, through twice throwing clothes lose vomiting more, it is ensured that day dosage be 4g/kg/d.Morbidity rule according to this disease
Rule, treatment cycle is 7 days.
Comparative example 2 groups: this group disease dog uses the Chinese medicinal tablet 3 of comparative example 2 of the present invention preparation, preferable for ordinary circumstance
Sick dog, uses Chinese medicinal tablet levigation, is added in disease dog feed and drinking-water, it is ensured that sick dog reaches 4g/ for the intake of Chinese medicine
Kg/d, medicine time is multiple dosing, not limiting time;For the sick dog that ordinary circumstance is poor, use stomach tube medication, cut-off
0.5 centimetre of footpath, the thin plastic pipe of long 40 centimetres are as stomach tube.After opening oral cavity, insert stomach tube, inject with syringe extraction medicinal liquid
Stomach tube.Owing to dog has vomiting habit, after extraction stomach tube after 3~5 minutes, common medicinal liquid spues, must be again with same after a few minutes of interval
The method of sample gavages once, through twice throwing clothes lose vomiting more, it is ensured that day dosage be 4g/kg/d.Morbidity rule according to this disease
Rule, treatment cycle is 7 days.
Western medicine group: the sick refined 5-linked serum of dog injection combines love Mao Er (bromisoval procaine), for ordinary circumstance relatively
Good sick dog, refined 5-linked serum injection amount is 1ml/kg, 1 times/day, likes that your injection volume of cyclopentadienyl is 2ml/ time, 1 times/day, to diet
And drinking-water does not processes;For the sick dog that ordinary circumstance is poor, refined 5-linked serum injection amount is 2ml/kg, 1 times/day, likes cyclopentadienyl
Your injection volume is 2ml/ time, 2 times/day, does not processes diet and drinking-water;According to the occurrence regularity of this disease, treatment cycle is 7
My god.
Observation index: after administration, observe dog diet, drink water, vomit, two just situations, observe the mental status of dog simultaneously.Right
In dying of illness, dog is analysed, and observes the change of each internal organs.
Result:
Sick dog treatment situation
Table 3 sick dog treatment situation
Group | N | Recovery from illness | Effectively | Die of illness | Cure rate | Mortality rate |
Invention group | 21 | 11 | 9 | 1 | 52.38%* | 4.8%* |
Comparative example 1 group | 21 | 4 | 6 | 11 | 19.05%# | 52.38%# |
Comparative example 2 groups | 21 | 4 | 13 | 4 | 19.05%# | 19.05%*# |
Western medicine group | 20 | 5 | 6 | 9 | 25.00% | 45.00% |
Compare with Western medicine group,*P < 0.05;Compare with invention group,#P < 0.05
By sick dog is treated the comparison of situation, the cure rate of Chinese medicinal tablet of the present invention is significantly higher than Western medicine group and compares
Example group, P < 0.05, mortality rate is substantially less than matched group and comparative example group, P < 0.05 simultaneously.Invention goes Rhizoma Coptidis group mortality rate to show
Write and increase, when illustrate that the consumption of Rhizoma Coptidis and charred Radix Sanguisorbae is very little, understand the therapeutic effect of appreciable impact parvovirus, the effect of antiviral
Weaken.
Sick dog ordinary circumstance
For dead sick dog, carry out ordinary circumstance observation, observe dog diet, drink water, vomit, two just situations, see simultaneously
Examine the mental status of dog.
The ordinary circumstance of the not dead sick dog of table 4
Compare with Western medicine group,*P < 0.05;Compare with invention group,#P < 0.05,##P < 0.01
By the dog that do not dies of illness is carried out ordinary circumstance observation, improve in vomiting, two just the changing of condition improved and mental status
On Shan, treatment group is significantly better than matched group, P < 0.05.Compare with invention group, when Chinese medicine preparation humus flava usta consumption of the present invention very little
Time, diet, drink water, vomit, two just situation and mental status all have notable significant difference, P < 0.05 or P < 0.01.
Chinese medicinal tablet of the present invention has good therapeutical effect for the sick dog of Canine parvovirus infection, reduces sick dog disease dead
Rate, improves the ordinary circumstance of sick dog simultaneously.There is good using value.And its prescription medicine need to keep former side's commercial weight, otherwise
Its drug effect goes down.After being evaluated by security related, Chinese medicine preparation of the present invention will be applicable to clinical application.
All above-mentioned primary these intellectual properties of enforcement, do not set this new product of enforcement limiting other forms
And/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar execution feelings
Condition.But, all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above, be only presently preferred embodiments of the present invention, is not the restriction that the present invention makees other form, appoints
What those skilled in the art changed possibly also with the technology contents of the disclosure above or be modified as equivalent variations etc.
Effect embodiment.But every without departing from technical solution of the present invention content, the technical spirit of the foundation present invention is to above example institute
Any simple modification, equivalent variations and the remodeling made, still falls within the protection domain of technical solution of the present invention.
Claims (7)
1. one kind for treating the medicine of Canine Parvovirus, it is characterised in that: crude drug include charred Radix Sanguisorbae, charred Flos Sophorae, Flos Lonicerae,
Rhizoma Coptidis, Cortex Phellodendri, Semen Plantaginis, the Radix Pulsatillae, Herba Portulacae, Herba Agrimoniae, Halloysitum Rubrum, Rhizoma Corydalis, Poria, Monas cuspurpureus Went, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched), grey
Art, humus flava usta, Radix Bupleuri, Rhizoma Cimicifugae and Radix Puerariae.
2. the medicine for treating Canine Parvovirus as claimed in claim 1, it is characterised in that: the weight portion of each crude drug divides
Wei charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 8 parts~12 parts, Flos Lonicerae 13 parts~17 parts, Rhizoma Coptidis 20 parts, Cortex Phellodendri 10 parts~14 parts, Herba Plantaginis
Son 13 parts~17 parts, the Radix Pulsatillae 13 parts~17 parts, Herba Portulacae 28 parts~32 parts, Herba Agrimoniae 28 parts~32 parts, Halloysitum Rubrum 8 parts~12
Part, Rhizoma Corydalis 28 parts~32 parts, 58 parts~62 parts of Poria, 18 parts~22 parts of Monas cuspurpureus Went, Radix Codonopsis 38 parts~42 parts, Rhizoma Atractylodis Macrocephalae (parched) 38 parts~
42 parts, Rhizoma Atractylodis 18 parts~22 parts, humus flava usta 40 parts, Radix Bupleuri 6 parts~10 parts, Rhizoma Cimicifugae 6 parts~10 parts, Radix Puerariae 28 parts~32 parts.
3. the medicine for treating Canine Parvovirus as claimed in claim 1 or 2, it is characterised in that: the weight of each crude drug
Part is respectively charred Radix Sanguisorbae 20 parts, charred Flos Sophorae 10 parts, Flos Lonicerae 15 parts, Rhizoma Coptidis 20 parts, Cortex Phellodendri 12 parts, Semen Plantaginis 15 parts, the Radix Pulsatillae
15 parts, Herba Portulacae 30 parts, Herba Agrimoniae 30 parts, Halloysitum Rubrum 10 parts, Rhizoma Corydalis 30 parts, 60 parts of Poria, 20 parts of Monas cuspurpureus Went, Radix Codonopsis 40 parts,
Rhizoma Atractylodis Macrocephalae (parched) 40 parts, Rhizoma Atractylodis 20 parts, humus flava usta 40 parts, Radix Bupleuri 8 parts, Rhizoma Cimicifugae 8 parts, Radix Puerariae 30 parts.
4. the medicine for treating Canine Parvovirus as described in claims 1 to 3, it is characterised in that: described medicine is prepared as
Tablet.
5. the preparation method of the medicine for treating Canine Parvovirus described in Claims 1-4, it is characterised in that: work as preparation
During piece agent, specifically,
The first step, pulverizes each crude drug respectively, mixes, use water extraction;
Second step, extracting solution concentrates, it is thus achieved that the effective extract component of medicine;
3rd step, the effective extract component of medicine that second step obtains is mixed homogeneously according to the mass ratio of 3: 2 with starch, adds
Excipients magnesium stearate, the addition of magnesium stearate is the 5% of starch and effective extract component mixing quality sum, is pressed into
Sheet, it is thus achieved that tablet.
6. the preparation method of the medicine for treating Canine Parvovirus as claimed in claim 5, it is characterised in that: described first
Step is specially further and is pulverized respectively by each crude drug, mixes, and adds the water boil of mixture quality 10 times, and maintenance 2 is little
Time, filtering, filtering residue adds the water boil of mixture quality 6 times again, maintains 1 hour, filters, and twice filtrate mixes, for the
Two steps concentrate.
7. the preparation method of the medicine for treating Canine Parvovirus as described in claim 5 or 6, it is characterised in that: described
Second step is that the hybrid filtering liquid first step obtained concentrates further, it is thus achieved that the mastic of 60 DEG C of relative densities 1.25, for the 3rd
Step uses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610548199.0A CN106039074A (en) | 2016-07-12 | 2016-07-12 | Tablets for treating canine parvovirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610548199.0A CN106039074A (en) | 2016-07-12 | 2016-07-12 | Tablets for treating canine parvovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106039074A true CN106039074A (en) | 2016-10-26 |
Family
ID=57186481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610548199.0A Pending CN106039074A (en) | 2016-07-12 | 2016-07-12 | Tablets for treating canine parvovirus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106039074A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107184915A (en) * | 2017-07-18 | 2017-09-22 | 北京农学院 | A kind of Chinese medicine composition for preventing and treating enteritis canine parvovirus and preparation method thereof |
JP2021512880A (en) * | 2018-01-31 | 2021-05-20 | スーチュワン インル ウェイトー ファーマスーティカル テクノロジー カンパニー リミテッド | Use of Bulbul extract in the manufacture of drugs to treat viral and / or bacterial diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057943A (en) * | 2007-05-18 | 2007-10-24 | 赵代良 | Medicine for treating dog parvovirus disease |
CN101670026A (en) * | 2009-08-28 | 2010-03-17 | 天津生机集团股份有限公司 | Chinese and western medicine composition for treating canine parvovirus infection and preparation method thereof |
-
2016
- 2016-07-12 CN CN201610548199.0A patent/CN106039074A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057943A (en) * | 2007-05-18 | 2007-10-24 | 赵代良 | Medicine for treating dog parvovirus disease |
CN101670026A (en) * | 2009-08-28 | 2010-03-17 | 天津生机集团股份有限公司 | Chinese and western medicine composition for treating canine parvovirus infection and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
张淑珍: "犬细小病毒病的诊断和治疗", 《甘肃畜牧兽医》 * |
舒晓红;等: "中西结合防治犬细小病毒病的研究进展", 《中国动物保健》 * |
陈加勤: "犬细小病毒性肠炎的诊断和治疗", 《安徽农学通报》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107184915A (en) * | 2017-07-18 | 2017-09-22 | 北京农学院 | A kind of Chinese medicine composition for preventing and treating enteritis canine parvovirus and preparation method thereof |
JP2021512880A (en) * | 2018-01-31 | 2021-05-20 | スーチュワン インル ウェイトー ファーマスーティカル テクノロジー カンパニー リミテッド | Use of Bulbul extract in the manufacture of drugs to treat viral and / or bacterial diseases |
JP7021360B2 (en) | 2018-01-31 | 2022-02-16 | スーチュワン インル ウェイトー ファーマスーティカル テクノロジー カンパニー リミテッド | Use of light-vented bulbul extract in the manufacture of drugs to treat viral and / or bacterial diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104012798A (en) | Feed for treating endometritis of sow, traditional Chinese medicine composition and preparation method | |
CN102784306A (en) | Traditional Chinese medicine composition and feed for treating piglet edema disease and preparation methods of traditional Chinese medicine composition and feed | |
CN102696928B (en) | Feed for curing swine flu, traditional Chinese medicine composition, preparation method thereof and application thereof | |
CN104147508A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
CN103239651B (en) | Traditional Chinese medicine for treating subclinical mastitis for dairy cow | |
CN102488847B (en) | Traditional Chinese medicine composition for treating chicken infectious bursal disease as well as preparation method and application thereof | |
CN106309877A (en) | Drug for preventing and treating porcine hemagglutinating encephalomyelitis viruses | |
CN103386100A (en) | Autumn diarrhea paste | |
CN102698158B (en) | Traditional Chinese medicine for preventing and treating infectious bronchitis, preparation method thereof and feed | |
CN104474104A (en) | Traditional Chinese medicine composition for preventing and treating infectious rhinitis of chicken and preparation method thereof | |
CN106039074A (en) | Tablets for treating canine parvovirus | |
CN102552657B (en) | Chinese medicinal composition used for treating Newcastle disease of chicken | |
CN103599458B (en) | Treatment fowl plague and the herbal mixture that human cases of bird flu | |
CN102228607B (en) | Oral liquid for treating swine unknown high fever | |
CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN104771578A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
CN103341151B (en) | Traditional Chinese medicine for treating chronic bronchitis | |
CN103041172B (en) | Traditional Chinese medicine composition for curing chronic nasosinusitis and preparation method thereof | |
CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
CN104491504B (en) | A kind of Chinese medicine preparation for treating pleural effusion disease | |
CN103877471B (en) | Traditional Chinese medicinal composition for treating porcine viral diarrhea and preparation method thereof | |
CN103623192B (en) | Medicine being used for the treatment of pig blue-ear disease and preparation method thereof | |
CN102671021B (en) | Chinese medicament for treating chronic catarrhal otitis media and preparation method | |
CN104491571A (en) | Medicament for treating throat pain and thirst and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161026 |